Heather Hampel, M.S., CGC, study co-chair and a genetic researcher with the City of Hope cancer center in Duarte, Calif. (IMAGE)
Caption
“Many people don’t realize that colorectal cancer can run in families. In fact, about 30% of colorectal cancer cases are linked to genetics, and around 15% of newly diagnosed patients have a gene change (called a pathogenic germline variant) that increases cancer risk,” said Heather Hampel, M.S., CGC, study co-chair and a genetic researcher with the City of Hope cancer center in Duarte, Calif. “Our study aims to improve communication between patients and families about the genetic risks of cancer in the hopes of catching or preventing colorectal cancers early when they are most easily treated.”
For more information on Alliance A212101 - Evaluation of Provider vs. Patient Mediated Cascade Genetic Testing of First-Degree Relatives of Patients with Newly Diagnosed Colorectal Cancer, visit ClinicalTrials.gov or https://bit.ly/CRCGene-Testing.
Credit
City of Hope
Usage Restrictions
none
License
Original content